Citations

Showing 10 of 108104 citations.

Bedside Multimarker Testing for Risk Stratification in Chest Pain Units: The Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) Study
Apple, Fred S. , Jaffe, Allan S. , Jaffe, Allan S.

Mayo Clinic

Circulation | October 8, 2018 | Volume: 104 | Issue: 22 | Pages: No page available

10.1161/circ.104.22.e125 Get It

Abstract WP82: Screening Individuals With Intracranial Aneurysms for Abdominal Aortic Aneurysm - the Brain and Aortic Aneurysm Screening (BAAS) Study
Lescure, Tyler N , Rosenbaum, Blake L. , Rahman, Shareena , Green, Ilana E. , Berthaud, Jimmy V. , Barrett, Kevin M. , Worrall, Bradford B. , Carrera, Joseph , Thomas, Matthew , Southerland, Andrew M. , Meschia, James F.

Mayo Clinic

Stroke | October 8, 2018 | Volume: 49 | Issue: Suppl_1 | Pages: No page available

10.1161/str.49.suppl_1.wp82 Get It

Introduction: Aneurysm rupture is associated with high mortality and morbidity, including both intracranial aneurysms (IA) and abdominal aortic aneurysms (AAA). Despite potential preemptive treatment in those identified prior to IA or AAA rupture, the evidence for whom to screen remains limited. IA and AAA share both environmental and genetic risk, and prior cost-effectiveness models suggest the potential efficacy of screening in these high-risk individuals. We hypothesized that reciprocal screening in those presenting with IA for AAA would yield positive results. Methods: The BAAS study sought to establish the co-prevalence of IA and AAA. In this arm of BAAS, we recruited patients presenting with IA and screened them for AAA using abdominal ultrasound (aU/S) at two sites: Mayo Clinic and the University of Virginia (UVA). All participants underwent a detailed interview to collect demographic, radiographic, and clinical data. At UVA, participants also received genetic counseling. Results: At Mayo Clinic, we enrolled and screened 81 consecutive patients with aSAH (3 patients with known AAA were excluded) with 3 (3.7%) positive aU/S for AAA. At UVA, we recruited 195 consecutive patients presenting with ruptured or unruptured IA and completed screening aU/S in 178 (93%). Only one (0.6%) had an AAA. Conclusion: The lower positive screening at UVA (0.6%) which enrolled both ruptured and unruptured IA compared to the 3.7% positive results at Mayo suggests that future efforts to identify who with IA might benefit from AAA screening should focus on those with aneurysmal subarachnoid hemorrhage (aSAH).
Abstract WP425: Influence of Medication on Presentation in Patients With Cavernous Malformation
Brown, Robert D. , Flemming, Kelly D. , Lanzino, Giuseppe

Mayo Clinic

Stroke | October 8, 2018 | Volume: 49 | Issue: Suppl_1 | Pages: No page available

10.1161/str.49.suppl_1.wp425 Get It

Background: There are concerns about use of certain medications in patients with cavernous malformations (CM) being deleterious such as antithrombotics. In addition, there are select medications such as statins, vitamin D, and NSAIDs which theoretically may have a positive effect on endothelial leakiness. We aimed to determine whether certain medications taken prior to the diagnosis of CM influenced the presentation to medical attention. Methods: We established a prospective cohort of patients with clinically diagnosed CM in 2015. Patients are interviewed at inception and clinical records reviewed. Specifically, several medications are recorded including the use of: antithrombotics, NSAIDs, estrogen, Vitamin E, Vitamin D, SSRI, statin, and multivitamin. Patients are followed prospectively. Data continues to be collected annually on outcome events (bleeding) and ongoing medication use. Results: These results are on the first 103 patients entered into the database. Sixty-four (62.1%) patients are male and the average age at diagnosis is 39.1 years. Sixty-three (61.1%) presented with symptoms and 40 (38.9%) were incidental findings at first diagnosis. Patients taking NSAIDs (p=0.0468), Vitamin D (p=0.035), and statins (p=0.0163) were more likely to present with an incidental CM compared to those who presented symptomatically (hemorrhage, seizure or focal neurologic deficit). There was no significant difference in symptomatic vs. asymptomatic presentation in patients taking estrogens, warfarin, clopidogrel, SSRI, or vitamin E prior to presentation. Conclusion: This data supports the theoretic role of vitamin D, NSAIDS, and statin use in stabilization of endothelial permeability. Ongoing data collection and prospective follow up will allow us to determine if ongoing use of these medications plays a role in reducing risk of future hemorrhage.
Abstract WP346: Frequency of Convexal Subarachnoid Hemorrhage in the General Population
Yost, Micah D. , Fiebelkorn, Catherine Arnold, Aakre, Jeremiah A. , Przybelski, Scott A. , Klaas, James P. , Petersen, Ronald, Graff‐Radford, Jonathan , Vemuri, Prashanthi , Rabinstein, Alejandro A. , Flemming, Kelly D. , Brown, Robert , Kantarci, Kejal , Mielke, Michelle M. , Knopman, David S. , Jack, Clifford R.

Mayo Clinic

Stroke | October 8, 2018 | Volume: 49 | Issue: Suppl_1 | Pages: No page available

10.1161/str.49.suppl_1.wp346 Get It

Background: Non-traumatic convexal subarachnoid hemorrhages (cSAH) in the elderly can be a manifestation of cerebral amyloid angiopathy (CAA) and predict future intracerebral hemorrhage risk. The frequency of cSAH in the elderly population is unknown. Our objective was to determine the frequency of convexal subarachnoid hemorrhage in a population-based study among individuals who underwent amyloid PET imaging. Methods: Between 11/29/2004 and 3/11/2017 there were 1,687 participants ages 50-years and older in the population-based Mayo Clinic Study of Aging (MCSA) with Pittsburgh compound B (PiB) PET imaging. All intracerebral hemorrhages among participants were identified utilizing the Rochester Epidemiology Project’s records linkage system, and records and images were reviewed to identify those with both symptomatic and asymptomatic convexal subarachnoid hemorrhage. Neuroimaging characteristics, demographics, medications, and ApoE genotype were recorded. Results: Four (0.23%) cSAHs were identified among the individuals who underwent PiB PET imaging. Three were women and median age was 73 (range: 67-84). cSAH occurred in the following locations: right frontal (3), and right parieto-occipital (1). Two went on to develop a lobar intracerebral hemorrhage at a median of 4.75 years after cSAH. Coexisting cerebral microbleeds were identified in one case. The APOE allele combinations of the four participants were: 3/3, 3/3, 2/2, and 2/3. On PiB PET imaging, the median SUVR was 1.81 (range: 1.38-2.34). Conclusion: cSAH is a relatively rare manifestation of CAA occurring in less than 1% of the general population, but may represent a subset with a high risk of future intracerebral hemorrhage. Half of the participants with cSAH had an APOE e2 allele.
Abstract WP238: Using the Adaptive Learning Model to Reduce Door to-Needle Time in Acute Ischemic Stroke
Adcock, Amelia , Dabir, Aman , Pawar, Gauri, Alvi, Muhammad

Mayo Clinic

Stroke | October 8, 2018 | Volume: 49 | Issue: Suppl_1 | Pages: No page available

10.1161/str.49.suppl_1.wp238 Get It

Introduction: A significant burden of acute ischemic stroke (AIS) can be decreased by timely administration of tissue plasminogen activator (tPA). Door-to-needle (DTN) time is a nationally reported quality measure for patients with AIS. In a majority of primary and comprehensive stroke centers, acute stroke care is provided by teams comprising of trainees (residents/fellows). Adaptive learning is a well-studied paradigm to improve the quality of medical education. Conceptually, this model consists of four parts starting with planning, and subsequently involving learning, assessing and adjusting. It is a learner driven process. Hypothesis: Utilizing the adaptive learning model will reduce DTN time in AIS patients who present to the emergency department of a rural, tertiary care medical center staffed by neurology residents. Methods: Successive patients who received IV tPA for AIS in the emergency department of our academic medical center between January 1, 2014 and December 31, 2016 were included in the study. During months 1-18 (pre-intervention) DTN times were not shared with residents. During months 19-36 of study (post-intervention), we utilized our monthly stroke meeting to share DTN times anonymously. Discussions were held and emphasis was placed on the processes which led to shorter DTN times. Residents assessed responses, planned changes, and made adjustments in real time. Descriptive statistics were used to analyze the data. Results: A total of 313 patients received IV tPA during the study period (150 pre-intervention, 171 post intervention period). After the implementation of the quality improvement initiative, mean and median DTN time significantly reduced from 54.7 minutes to 43.0 minutes (p<0.0001) and 52 minutes to 39 minutes (p<0.0001) respectively. Conclusions: Our study exemplifies the success of the adaptive learning model in the care of patients with acute ischemic stroke. Our quality intervention led to significantly reduced DTN times. Furthermore, this educational initiative provided residents with objective feedback about their performance - one of the requirements of the accredited council of graduate medical education (ACGME).
Abstract WP196: Prevalence of Stroke in Argentina: A Population Based Epidemiological Study (EstEPA)
Gomw-Schneider, Maia M, Rodríguez-Lucci, Federico, Povedano, Guillermo , Melcon, Mario O., Lereis, Virginia Pujol , Dossi, Daiana , Hawkes, Maximiliano A. , Alet, Matías , González, Claudio Daniel , Ameriso, Sebastian Francisco

Mayo Clinic

Stroke | October 8, 2018 | Volume: 49 | Issue: Suppl_1 | Pages: No page available

10.1161/str.49.suppl_1.wp196 Get It

Introduction and objectives: Stroke is a leading cause of mortality and disability worldwide. Regional data is essential to assess the local impact of the disease and to plan rational adjudication of public health resources. Stroke prevalence data in Latin America are scant with only one prevalence study completed in Argentina in 1991. We determined prevalence of stroke in a sample representative of the Argentinean population. Methods: EstEPA is a population-based study to assess the prevalence, incidence and mortality of stroke in General Villegas, Buenos Aires, Argentina. A prevalence study was performed in two phases in an urban area of 18,275 habitants. First, a door-to-door survey of randomly selected houses was taken using a structured questionnaire for the detection of possible strokes. This was followed by a neurological evaluation for final adjudication. Data about stroke subtypes, vascular risk factors, medications and diagnostic tests were collected. Results: A total of 2156 door-to-door surveys were conducted and 294 were positive for possible stroke. After neurological evaluation, there were 41 confirmed stroke cases. The prevalence of stroke adjusted to Argentinean population older than 40 years was 1981 per 100,000 habitants with higher prevalence in men than women (27,75‰ vs 13,72‰, p=0.003). Prevalence increased with age with a higher prevalence at 70-75 years. Prevalence was 16.5‰ for ischemic stroke and 3‰ for intraparenchymal hemorrhage. Also, 6 transient ischemic attacks were diagnosed with a prevalence of 3‰. Most common vascular risk factors in stroke cases were hypertension (88%), obstructive sleep apnea (51%) and dyslipidemia (46%). At the time of evaluation 88% of ischemic stroke subjects were taking antiplatelets and/or anticoagulants. Conclusion: Approximately 2% of subjects older than 40 years are stroke survivors. This prevalence, likely representative of the Argentinean population at large, was higher than previously described in the region. It was comparable to data from Western developed countries with similar age and gender distribution. Aging of the Argentinean population in recent years and better preventive strategies may be responsible, at least in part, for these findings.
Abstract WMP56: Genetics of Acute Ischemic Lesion Volume: the MRI-Genetics Interface Exploration (MRI-GENIE) Study
Xu, Huichun , Donahue, Kathleen, McArdle, Patrick F. , Jiménez-Conde, Jordi , Kleindorfer, Dawn , Schmidt, Reinhold, Sharma, Pankaj , Słowik, Agnieszka , Woo, Daniel , Worrall, Bradford B. , Kittner, Steven J. , Rosand, Jonathan, Golland, Polina , Rost, Natalia S. , Giese, Anne‐Katrin , Schirmer, Markus D. , Dalca, Adrian Vasile , Gaynor, Brady J. , Cole, John W. , Broderick, Joseph P. , Jern, Christina , Kissela, Brett , Lemmens, Robin , Lindgren, Arne G. , Rundek, Tatjana , Sacco, Ralph L. , Thijs, Vincent , Meschia, James F. , Rosand, Jonathan M. , Mitchell, Braxton D. , Wu, Ona

Mayo Clinic

Stroke | October 8, 2018 | Volume: 49 | Issue: Suppl_1 | Pages: No page available

10.1161/str.49.suppl_1.wmp56 Get It

Introduction: Genome-wide association (GWA) studies have contributed substantially to the understanding of complex vascular traits including ischemic stroke; however, genetic determinants of acute cerebral ischemia remain to be elucidated. Objective: To investigate the genetic architecture of cerebral infarct lesion burden in patients with acute ischemic stroke (AIS). Methods: Twelve international sites contributed 3,301 AIS subjects with acute MRI and genome-wide genotyping to the MRI-GENIE study. In a preliminary analysis of 657 subjects of European ancestry, acute cerebral infarct lesions were outlined on diffusion-weighted images (DWI) using a semi-automated volumetric method. Standard quality control measures were performed per single nucleotide polymorphism (SNP) and per subject. SNPs were imputed to the Haplotype Reference Consortium v1.1 panel. Natural log-transformed DWI volume was used for GWA analysis with allelic dosage per SNP, age, sex and principal components 1-5 of genetic ancestry as covariates. Results: GWA testing for DWI volume in 7.7 million SNPs yielded no signal crossing the Bonferroni-corrected genome-wide significance threshold of p <5*10 -8 . However, several loci passed the nominal significance threshold of p <1*10 -6 (Figure 1), including a locus on chromosome 2 in the SPATA3-AS1 (spermatogenesis associated 3 antisense RNA 1) gene (lead SNP: rs2368999, MAF=36%, p =8.4*10 -7 ) and an intronic locus on chromosome 10 in the ATRNL1 (Attractin like 1) gene (lead SNP: rs592284, MAF=10%, p =9.1*10 -7 ). Conclusion: In this first-to-date, preliminary GWAS of acute cerebral infarct volume in AIS patients, we identified several new, nominally significant loci including a locus in ATRNL1, a gene previously linked to carotid plaque burden. Further analyses of the MRI-GENIE cohort to replicate these findings, to include stroke subtype specific analyses, and to increase the overall statistical power of the study are ongoing.
Abstract WMP51: Towards a Simplified Method for Ischemic Stroke Subtyping Suitable for Electronic Medical Record Systems
Ay, Hakan , Worrall, Bradford B. , McArdle, Patrick F. , Brown, Robert D. , Rundek, Tatjana , Grewal, Raji P., Kittner, Steven J. , Ryan, Kathleen A. , Cole, John W. , Meschia, James F. , Abedi, Vida , Zand, Ramin , Wassertheil-Smoller, Sylvia W , Sudlow, Cathie , Sacco, Ralph L. , Rexrode, Kathryn M. , Lindgren, Arne G. , McDonough, Caitrin W. , Ribasés, Marta , Mitchell, Braxton D.

Mayo Clinic

Stroke | October 8, 2018 | Volume: 49 | Issue: Suppl_1 | Pages: No page available

10.1161/str.49.suppl_1.wmp51 Get It

Background: Current ischemic stroke (IS) subtyping systems are very labor-intensive and costly to implement in large samples. There is a need to develop phenotyping approaches for genetic and other studies that can be implemented using generally available items captured in electronic medical records. Objective: In this report, we seek to validate a simplified approach using results from a genetic association study. Specifically, the strength of association for known genetic signals in the NINDS Stroke Genetics Network study (SiGN) is compared between the established IS subtyping systems (TOAST and Causative Classification System (CCS) subtypes) and phenotyping based on a single item within the CCS. Methods: Non-mutually exclusive “Simple” IS subtypes were defined from single CCS items as follows: 1) Small vessel stroke- lacunar infarct on imaging (with no other imaging or other requirements); 2) large artery stroke - vascular imaging showing > 50% stenosis or <50% stenosis with plaque rupture or thrombosis judged to be due to atherosclerosis in clinically relevant artery; and 3) cardioembolic stroke - persistent or paroxysmal atrial fibrillation. We compared the GWAS signals using these definitions to the published SiGN GWAS results for TOAST and CCS, among those of European ancestry only. Results: The Table shows that, for loci significant in SiGN GWAS study, the “Simple” IS subtypes had similar strengths of association and p-values compared to results from TOAST and the causative and phenotypic CCS subtypes. Conclusions: “Simple” IS subtypes perform as well in GWAS analyses as more complex phenotyping systems and could potentially be derived through automated or semi-automated methods applied to electronic medical record systems. Since the ‘Simple” phenotypes were based on high quality CCS data, the current findings reflect optimal performance. Additional validation studies will be required for implementation in other settings.
Abstract TP82: Changes in the Distal Vessel Wall After Flow Diverter Treatment
Parameswaran, Praveen Kolumam, Ding, Yong Hong, Asnafi, Solmaz , Urban, Matthew M, Kallmes, David F. , Kadirvel, Ramanathan , Dai, Daying , Ding, Yonghong

Mayo Clinic

Stroke | October 8, 2018 | Volume: 49 | Issue: Suppl_1 | Pages: No page available

10.1161/str.49.suppl_1.tp82 Get It

Background: Flow diverters (FD) are increasingly used in the treatment of intracranial aneurysms. The risk of distal thromboembolic complications with FD is high, even in patients treated with dual antiplatelet therapy. The aim of the study was to understand the downstream vascular wall changes, by measuring the pulse wave velocity and vascular contractility following flow diverter treatment in a rabbit model. Methods: FD (Pipeline Embolic Device, Medtronic) were implanted in normal rabbits and sham-operated aorta were used as controls (n=5 for each group). Pulse wave imaging with ultra-fast ultrasound at 1600 frames per second (Vantage, Verasonics, Inc.) was performed in the vessel wall distal to FD, prior to device implantation and at 8 weeks follow up to measure the pulse wave propagation. Force contraction studies were conducted in the aortic rings using organ bath to assess the vascular functions. Results: The difference in pulse wave velocity (PWV) in the follow-up compared to pre-implantation was significantly higher (p=0.03,Fig 1A) in the distal vessels compared to sham controls (mean difference of PWV was 1.18 m/s and -0.37m/s, respectively as shown in Fig 1B). Conversely, the distal aortic segments to FD exhibited 55% increase in the level of vascular contractility compared to that of proximal segments (p=0.002). There is a significant positive correlation between mean PWV and mean vascular contractility. Conclusion: Our study found changes in the PWV after implantation of the FD, which correlated with vascular contractility. These results could explain vascular wall changes downstream following FD implantation.
Abstract TP54: Machine-Learned Characterization of Acute Ischemic Stroke Clots Reveals a Correlation Between Clot Composition and Density on CT
Wang, Shunli , Murphree, Dennis H. , Douglas, Andrew , Kadirvel, Ramanathan , Brinjikji, Waleed , Kallmes, David F. , Karen, Doyle M, Fitzgerald, Seán , Dai, Daying , Pandit, Abhay

Mayo Clinic

Stroke | October 8, 2018 | Volume: 49 | Issue: Suppl_1 | Pages: No page available

10.1161/str.49.suppl_1.tp54 Get It

Introduction: The composition of acute ischemic stroke (AIS) blood clots can impact their successful removal via endovascular therapy. Identification of the clot composition prior to endovascular treatment may influence the optimal treatment strategy. In this study, we aimed to investigate the relationship between the Hounsfield Unit intensity on CT and machine-learned characterization of clot composition. Methods: Prior to endovascular treatment, each patient had a non-contrast CT performed. Histopathological analysis of the clots was performed and clot composition was quantified via standard thresholding techniques using Adobe Photoshop. In addition, following representative cell labeling by an expert pathologist, image segmentation algorithms (Orbital Image Analysis, Actelion Ltd.) were trained on each case to quantify composition by cell type. The clots were categorized into 3 groups: red blood cell (RBC) dominant (>50%), RBC proportion equal to fibrin and fibrin dominant (>50%). Correlations between clot composition and Hounsfield Units (HU) density on CT were assessed. A positive Hyperdense Artery Sign was defined as ≥50 HU. Results: Twenty patients were included in the study. There was a significant correlation between clots quantified using Adobe Photoshop Image-Pro and Orbit image analysis ( ρ = 0.837, p < 0.001). A significant relationship was found between clot composition and the presence of a HAS sign, ( X 2 (2) = 6.496, p = 0.039). There is a significant positive correlation between percentage of RBC in the clot and the presence of a HAS sign ( ρ = 0.632, p = 0.002**). There is also a significant positive correlation between the presence of fibrin-rich and the absence of a HAS sign ( ρ = 0.600, p = 0.004**). Conclusion: Machine learning software can accurately quantify AIS clot composition. The Hounsfield unit density of an AIS clot on a non-contrast CT correlates with the composition of the clot. Measuring the HU of the clot on CT prior to endovascular intervention may inform the clinician of the clot type and help to determine the most appropriate treatment strategy for that clot.